Table 1.
Estimated burden of serious fungal infections in Azerbaijan.
| Number of patients with underlying disorder |
Rate per 100,000 | Total burden | |||||
|---|---|---|---|---|---|---|---|
| Nonea | Respiratory | HIV/AIDS | Cancer/Tx | ICU | |||
| Oesophageal candidiasis | – | – | 579 | – | – | 5.8 | 579 |
| Oral candidiasis | – | – | 808 | – | – | 8.1 | 808 |
| Candidemia | – | – | – | – | 499 | 5 | 499 |
| Candida peritonitis | – | – | – | – | 75 | 0.75 | 75 |
| RVVC | 159,489 | – | – | – | – | 3196 | 159,489 |
| ABPA | – | 4927 | – | – | – | 49.37 | 4927 |
| SAFS | – | 6504 | – | – | – | 65.16 | 6504 |
| CPA after TB | – | 577 | – | – | – | 5.8 | – |
| CPA total | – | 2307 | – | – | – | 86.8 | 2307 |
| IA | – | 36 | – | 81 | 577 | 7.0 | 693 |
| Cryptococcal meningitis | – | – | 5 | – | – | 0.05 | 5 |
| Pneumocystis pneumonia | – | – | 55 | – | – | 0.55 | 55 |
| Mucormycosis | – | – | – | 20 | – | 0.2 | 20 |
| Fungal keratitis | unk | – | – | ? | – | 0.12 | 12 |
| Allergic fungal sinusitis | 50,000 | – | – | – | – | 50 | 50,000 |
| Estimated total burden | 209,489 | 14,351 | 1447 | 101 | 1151 | – | 225,974 |
a
Population at risk without underlying condition.
ABPA, allergic bronchopulmonary aspergillosis; AIDS, acquired immune deficiency syndrome; CPA, chronic pulmonary aspergillosis; HIV, human immune deficiency virus; IA, invasive aspergillosis; ICU, intensive care unit; SAFS, severe asthma with fungal sensitization; RVVC, recurrent vulvovaginal candidiasis; unk, unknown.